Nature's hidden value, made real.
Every year, industries use only part of what nature offers. Fruit pulp. Marine co-products. Agricultural residues. Fermentation waste. Set aside. Not because it has no value.
Because no one has looked carefully enough.
BioMyne maps what is actually present in a natural material, then develops what it finds into ingredients, materials, and products worth building.
This is not sustainability positioning. It is a systematic, AI-guided process built on green chemistry, holistic fraction science, and IP-conscious development.
Artificial Learning for Compound Harvesting and Extraction
ALCHEMIST™ reads a natural material and maps everything it could become across health, materials, and construction. It directs discovery and process together, and it learns from every project.
A modular system for turning natural materials into defined, high-value outputs across health, materials, and construction.
The central intelligence. Reads every material, maps every possibility, and directs the system.
Patent PendingDevelops promising natural compounds into validated health, skin, and nutrition pathways.
Turns natural and mineral fractions into building blocks for construction, engineering, and advanced materials.
Connects all platforms and ensures the highest combined value from everything a material contains.
Three materials most industries set aside. Three examples of what systematic discovery finds inside them.
Eggshell membrane contains structural proteins and precursors relevant to skin and connective tissue. BioMyne is characterising active fraction profiles for health and cosmeceutical applications.
BioMyne is applying ALCHEMIST™ to characterise and develop specific polymethoxylated flavonoid and polyphenolic fractions from processing co-streams in the Pearl River Delta.
Fermentation systems can produce biological materials with purity, biocompatibility, and structural performance that conventional processes struggle to match.
Representative programme directions only. No regulatory timelines or commercial commitments implied.
A directional view of active programmes — no regulatory timelines or commercial commitments implied.
| Programme | Discovery | Development | Validation | Scale-Up | Commercial |
|---|---|---|---|---|---|
ALCHEMIST™ Platform Core AI Intelligence · B2B Licensing | |||||
Eggshell Membrane Bioactives ALCHEMIST™ · PHOENIX™ · Cosmeceutical & Nutraceutical | |||||
Xinhui Chen Pi Fractions ALCHEMIST™ · PHOENIX™ · Nutraceutical & Functional Food | |||||
Marine Processing Co-streams ALCHEMIST™ · PHOENIX™ · Health | |||||
Mineral & Inorganic Recovery ARCHITECT™ · Construction & Materials | |||||
Fermentation-derived Biomaterials ARCHITECT™ · PHOENIX™ · Strategic Pipeline | |||||
SYMBIOSIS™ Integration Full-system orchestration |
Directional only · No regulatory timelines implied · Updated as programmes advance
BioMyne works with industry, investors, and research institutions. What they share is a conviction that natural materials contain more value than is currently being found.
We map what is actually in it, identify realistic high-value applications, and develop them alongside you.
ALCHEMIST™ provides a bio-intelligence partner with IP thinking built in from day one.
Not a story. A technology company with protected IP, a real pipeline, and multiple licensing and product pathways.
If you have a natural material and want to know what it could become —
Start a conversationNature produces far more value than industries currently capture — not because the value is not there, but because the tools to find it have not existed until now. BioMyne has built those tools.
Founded in Macau at the intersection of artificial intelligence, circular bioeconomy, and high-value bioactive compound development. DSEDT-certified. Multiple FDCT-funded programmes. Research collaborations across Macau and Portugal. Registered in Hengqin and building long-term commercial relevance across the GBA and Lusophone markets.
Whether you have a natural material to explore, a product that needs a bio-intelligence layer, or an investment thesis to validate — the right starting point is a conversation.